142 related articles for article (PubMed ID: 27549341)
1. Polymorphisms in drug-metabolizing enzymes and steady-state exemestane concentration in postmenopausal patients with breast cancer.
Hertz DL; Kidwell KM; Seewald NJ; Gersch CL; Desta Z; Flockhart DA; Storniolo AM; Stearns V; Skaar TC; Hayes DF; Henry NL; Rae JM
Pharmacogenomics J; 2017 Dec; 17(6):521-527. PubMed ID: 27549341
[TBL] [Abstract][Full Text] [Related]
2. Associations between genetic variants and the effect of letrozole and exemestane on bone mass and bone turnover.
Oesterreich S; Henry NL; Kidwell KM; Van Poznak CH; Skaar TC; Dantzer J; Li L; Hangartner TN; Peacock M; Nguyen AT; Rae JM; Desta Z; Philips S; Storniolo AM; Stearns V; Hayes DF; Flockhart DA
Breast Cancer Res Treat; 2015 Nov; 154(2):263-73. PubMed ID: 26536870
[TBL] [Abstract][Full Text] [Related]
3. [Late phase II study of exemestane in postmenopausal patients with breast cancer resistant to anti-estrogenic agents].
Watanabe T; Sano M; Toi M; Saeki T; Kanda K; Miura S; Inaji H; Sono H; Saeki H; Nishimura R; Fujita Y
Gan To Kagaku Ryoho; 2002 Jul; 29(7):1211-21. PubMed ID: 12146002
[TBL] [Abstract][Full Text] [Related]
4. Predictive pharmacogenetic biomarkers for breast cancer recurrence prevention by simvastatin.
Ahern TP; Damkier P; Feddersen S; Kjærsgaard A; Lash TL; Hamilton-Dutoit S; Lythjohan CB; Ejlertsen B; Christiansen PM; Cronin-Fenton DP
Acta Oncol; 2020 Sep; 59(9):1009-1015. PubMed ID: 32351149
[No Abstract] [Full Text] [Related]
5. Double-blind, randomized placebo controlled trial of fulvestrant compared with exemestane after prior nonsteroidal aromatase inhibitor therapy in postmenopausal women with hormone receptor-positive, advanced breast cancer: results from EFECT.
Chia S; Gradishar W; Mauriac L; Bines J; Amant F; Federico M; Fein L; Romieu G; Buzdar A; Robertson JF; Brufsky A; Possinger K; Rennie P; Sapunar F; Lowe E; Piccart M
J Clin Oncol; 2008 Apr; 26(10):1664-70. PubMed ID: 18316794
[TBL] [Abstract][Full Text] [Related]
6. Exemestane for advanced breast cancer.
Med Lett Drugs Ther; 2000 Apr; 42(1076):35-6. PubMed ID: 10803175
[No Abstract] [Full Text] [Related]
7. [Phase I single-dose administration study of exemestane in postmenopausal women].
Miura S; Tominaga T; Koyama H; Nomura Y; Tsuboi M
Gan To Kagaku Ryoho; 2002 Jul; 29(7):1179-87. PubMed ID: 12145999
[TBL] [Abstract][Full Text] [Related]
8. Carpal tunnel syndrome and musculoskeletal symptoms in postmenopausal women with early breast cancer treated with exemestane or tamoxifen after 2-3 years of tamoxifen: a retrospective analysis of the Intergroup Exemestane Study.
Mieog JS; Morden JP; Bliss JM; Coombes RC; van de Velde CJ;
Lancet Oncol; 2012 Apr; 13(4):420-32. PubMed ID: 22265698
[TBL] [Abstract][Full Text] [Related]
9. Effect of exemestane on tamoxifen pharmacokinetics in postmenopausal women treated for breast cancer.
Hutson PR; Love RR; Havighurst TC; Rogers E; Cleary JF
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8722-7. PubMed ID: 16361559
[TBL] [Abstract][Full Text] [Related]
10. Quality of life in the intergroup exemestane study: a randomized trial of exemestane versus continued tamoxifen after 2 to 3 years of tamoxifen in postmenopausal women with primary breast cancer.
Fallowfield LJ; Bliss JM; Porter LS; Price MH; Snowdon CF; Jones SE; Coombes RC; Hall E
J Clin Oncol; 2006 Feb; 24(6):910-7. PubMed ID: 16484701
[TBL] [Abstract][Full Text] [Related]
11. Activity of exemestane in metastatic breast cancer after failure of nonsteroidal aromatase inhibitors: a phase II trial.
Lønning PE; Bajetta E; Murray R; Tubiana-Hulin M; Eisenberg PD; Mickiewicz E; Celio L; Pitt P; Mita M; Aaronson NK; Fowst C; Arkhipov A; di Salle E; Polli A; Massimini G
J Clin Oncol; 2000 Jun; 18(11):2234-44. PubMed ID: 10829043
[TBL] [Abstract][Full Text] [Related]
12. Skeletal effects of exemestane on bone-mineral density, bone biomarkers, and fracture incidence in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES): a randomised controlled study.
Coleman RE; Banks LM; Girgis SI; Kilburn LS; Vrdoljak E; Fox J; Cawthorn SJ; Patel A; Snowdon CF; Hall E; Bliss JM; Coombes RC;
Lancet Oncol; 2007 Feb; 8(2):119-27. PubMed ID: 17267326
[TBL] [Abstract][Full Text] [Related]
13. Falsely elevated serum oestradiol due to exemestane therapy.
Mandic S; Kratzsch J; Mandic D; Debeljak Z; Lukic I; Horvat V; Gaudl A; Seric V
Ann Clin Biochem; 2017 May; 54(3):402-405. PubMed ID: 27687081
[TBL] [Abstract][Full Text] [Related]
14. Disease-related outcomes with long-term follow-up: an updated analysis of the intergroup exemestane study.
Bliss JM; Kilburn LS; Coleman RE; Forbes JF; Coates AS; Jones SE; Jassem J; Delozier T; Andersen J; Paridaens R; van de Velde CJ; Lønning PE; Morden J; Reise J; Cisar L; Menschik T; Coombes RC
J Clin Oncol; 2012 Mar; 30(7):709-17. PubMed ID: 22042946
[TBL] [Abstract][Full Text] [Related]
15. Exemestane in postmenopausal women with early or advanced breast cancer: a review.
Bertelli G; Gangadhara S
Expert Opin Pharmacother; 2010 Aug; 11(11):1933-42. PubMed ID: 20569090
[TBL] [Abstract][Full Text] [Related]
16. Exemestane versus anastrozole as front-line endocrine therapy in postmenopausal patients with hormone receptor-positive, advanced breast cancer: final results from the Spanish Breast Cancer Group 2001-03 phase 2 randomized trial.
Llombart-Cussac A; Ruiz A; Antón A; Barnadas A; Antolín S; Alés-Martínez JE; Alvarez I; Andrés R; García Saenz JA; Lao J; Carrasco E; Cámara C; Casas I; Martín M
Cancer; 2012 Jan; 118(1):241-7. PubMed ID: 21717449
[TBL] [Abstract][Full Text] [Related]
17. Liquid chromatography tandem mass spectrometry determination of free and conjugated estrogens in breast cancer patients before and after exemestane treatment.
Zhao Y; Boyd JM; Sawyer MB; Li XF
Anal Chim Acta; 2014 Jan; 806():172-9. PubMed ID: 24331053
[TBL] [Abstract][Full Text] [Related]
18. A Randomized, Placebo-Controlled, Phase II, Presurgical Biomarker Trial of Celecoxib Versus Exemestane in Postmenopausal Breast Cancer Patients.
Aristarco V; Serrano D; Gandini S; Johansson H; Macis D; Guerrieri-Gonzaga A; Lazzeroni M; Feroce I; Pruneri G; Pagani G; Toesca A; Caldarella P; DeCensi A; Bonanni B
Cancer Prev Res (Phila); 2016 May; 9(5):349-56. PubMed ID: 26928670
[TBL] [Abstract][Full Text] [Related]
19. The effect of exemestane on the lipidemic profile of postmenopausal early breast cancer patients: preliminary results of the TEAM Greek sub-study.
Markopoulos C; Polychronis A; Zobolas V; Xepapadakis G; Papadiamantis J; Koukouras D; Lappas H; Gogas H
Breast Cancer Res Treat; 2005 Sep; 93(1):61-6. PubMed ID: 16184460
[TBL] [Abstract][Full Text] [Related]
20. Exemestane: a review of its use in postmenopausal women with advanced breast cancer.
Clemett D; Lamb HM
Drugs; 2000 Jun; 59(6):1279-96. PubMed ID: 10882163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
